ABVC · Abvc Biopharma, Inc. · Exempt Offerings
$0.91
-0.07 (-7.14%)
At close · Oct 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“For the six months ended June 30, 2026, the Company reported net loss of $2,500,418. As of June 30, 2026, the Company's working capital deficit was $5,282,776. In addition, the Company had net cash outflows of $1,138,656 from operating activities for the six months ended June 30, 2026. These conditions give rise to substantial doubt as to whether the Company will be able to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Market Cap
$29.29M
Shares
26.65M
Volume · Oct 5
93.53K
Avg daily vol (3M)
131.85K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.